v3.26.3
Segment Information (Tables)
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Segment Reporting
Information regarding industry segments at September 30, 2026 and 2025 and for the three months then ended is as follows (in millions):
Life
Science		Clinical
Diagnostics
Net sales2026$254.6 $401.8 
2025$261.8 $391.2 
Cost of goods sold
2026$122.4 $205.4 
2025$115.9 $193.7 
Segment gross profit2026$132.2 $196.4 
2025$145.9 $197.5 
Depreciation and amortization
2026$17.8 $23.4 
2025$20.6 $23.6 
Segment assets
2026$301.3 $482.6 
2025$310.9 $472.3 
Segment Reporting, Reconciliation of Profit (Loss) by Segment to Consolidated
The following reconciles total segment gross profit to net income (loss) before income taxes (in millions):
Three Months EndedNine Months Ended
September 30,September 30,
2026202520262025
Segment gross profit$328.6 $343.4 $983.8 $994.7 
Selling, general and administrative expense
(257.1)(206.8)(681.5)(623.3)
Research and development expense
(71.4)(71.3)(195.5)(205.3)
Impairment of purchased intangibles(49.8)— (49.8)— 
Interest expense(12.3)(12.3)(36.7)(36.9)
Foreign currency exchange gains, net2.1 2.9 4.7 4.5 
Gains (losses) from change in fair market value of equity securities and loan receivable588.2 (495.3)308.0 (129.1)
Other income, net10.4 8.3 58.0 61.7 
Income (loss) before income taxes$538.7 $(431.1)$391.0 $66.3